Skip to main content
Clinical Trials/NCT03319225
NCT03319225
Completed
Not Applicable

A Study of the Distal Gut Microbiome and Its Relation to Gastrointestinal Transit After Spinal Cord Injury

University of Miami1 site in 1 country5 target enrollmentDecember 18, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Cord Injury
Sponsor
University of Miami
Enrollment
5
Locations
1
Primary Endpoint
Characterize microbiome composition
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this research study is to learn more about the causes of gastrointestinal dysfunction after spinal cord injury. It has been thought that the microbiome (the community of bacteria in the body) may be one such cause. The study will examine whether changes in the distal gut microbiome are related to gastrointestinal dysfunction in persons with Spinal Cord Injury and Non-Disabled Controls.

Registry
clinicaltrials.gov
Start Date
December 18, 2017
End Date
January 9, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mark S. Nash, Ph.D., FACSM

Professor

University of Miami

Eligibility Criteria

Inclusion Criteria

  • ≥ 1 year post-injury
  • Spinal cord injury resulting in Tetraplegia or Paraplegia (C5-T6) and motor complete or incomplete (AIS A-C) impairment. Injury level and impairment will be confirmed by an American Spinal Injury Association (ASIA) exam conducted less than 2 years before study entry. If longer than 2 years, a certified rater will repeat the exam.
  • Self -reported history of constipation or other gastrointestinal dysfunction (e.g., extended bowel care time or difficulty in bowel emptying)
  • Willingness to participate in the study

Exclusion Criteria

  • Currently hospitalized
  • American Spinal Injury Association (AIS) D-E
  • Self-reported history of Crohn's disease or diverticulitis, gastric blockage/obstruction or swallowing disorder
  • Gastrointestinal surgery ≤ 3 months prior to study
  • Implanted cardiac pacemaker, spinal cord stimulator, morphine (pain), or intrathecal pump
  • Concurrent use of surface functional electrical stimulation (FES)
  • Neurologically-Intact Persons:
  • Inclusion Criteria:
  • Age 18 or over
  • Willingness to participate in the study

Outcomes

Primary Outcomes

Characterize microbiome composition

Time Frame: Study day 7

Characterize the distal gut microbiome within and across the three groups

Secondary Outcomes

  • Gastrointestinal transit time(Study day 5)
  • Autonomic state(Baseline)
  • Inflammatory state(Baseline)

Study Sites (1)

Loading locations...

Similar Trials